Formulation and development of orodispersible sustained release tablet of domperidone

References

• Slavkova M, Breitkreutz J. Orodispersible drug formulations for children and elderly. Eur J Pharm Sci 2015;75:2–9.
   PubMed Web of Science ®Google Scholar
• Stegemann S, Gosch M, Breitkreutz J. Swallowing dysfunction and dysphagia is an unrecognized challenge for oral drug therapy. Int J Pharm 2012;430:197–206.
   PubMed Web of Science ®Google Scholar
• Dobetti L. Fast-melting tablets: developments and technologies. Pharm Tech 2000;12:32–42.
   Google Scholar
• Liew KB, Tan YTF, Peh KK. Taste-masked and affordable donepezil hydrochloride orally disintegrating tablet as promising solution for non-compliance in Alzheimer’s disease patients. Drug Dev Ind Pharm 2015;41:583–93.
   PubMed Web of Science ®Google Scholar
• Guhmann M, Preis M, Gerber F, et al. Design, development and in-vitro evaluation of diclofenac taste-masked orodispersible tablet formulations. Drug Dev Ind Pharm 2015;41:540–51.
   PubMed Web of Science ®Google Scholar
• Manyikana M, Choonara YE, Tomar LK, et al. A review of formulation techniques that impact the disintegration and mechanical properties of orodispersible drug delivery technologies. Pharm Dev Technol 2015;1–13.
   PubMed Web of Science ®Google Scholar
• Gugulothu D, Desai P, Pandharipande P, Patravale V. Freeze drying: exploring potential in development of orodispersible tablets of sumatriptan succinate. Drug Dev Ind Pharm 2015;41:398–405.
   PubMed Web of Science ®Google Scholar
• Spierings EL, Rapoport AM, Dodick DW, Charlesworth B. Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet. CNS Drugs 2004;18:1133–34.
   PubMed Web of Science ®Google Scholar
• Tábi T, Szökő E, Vécsei L, Magyar K. The pharmacokinetic evaluation of selegiline ODT for the treatment of Parkinson's disease. Expert Opin Drug Metab Toxicol 2013;9:629–36.
   PubMed Web of Science ®Google Scholar
• Roger A, Fortea J, Mora S, Artés M. Ebastine fast-dissolving tablets versus regular tablets: acceptability and preference in patients with allergic rhinitis. Expert Rev Clin Pharmacol 2008;1:381–9.
   PubMedGoogle Scholar
• Bitter I, Treuer T, Dilbaz N, et al. Patients' preference for olanzapine orodispersible tablet compared with conventional oral tablet in a multinational, randomized, crossover study. The World J Biol Psychiatry 2010;11:894–903.
   PubMed Web of Science ®Google Scholar
• Dowson AJ, Almqvist P. Part III: the convenience of, and patient preference for, zolmitriptan orally disintegrating tablet. Curr Med Res Opin 2005;21:S13–7.
   PubMed Web of Science ®Google Scholar
• Efentakis M, Naseef H, Vlachou M. Two- and three-layer tablet drug delivery systems for oral sustained release of soluble and poorly soluble drugs. Drug Dev Ind Pharm 2010;36:903–16.
   PubMed Web of Science ®Google Scholar
• Huang YT1, Tsai TR, Cheng CJ, et al. Formulation design of an HPMC-based sustained release tablet for pyridostigmine bromide as a highly hygroscopic model drug and its in vivo/in vitro dissolution properties. Drug Dev Ind Pharm 2007;33:1183–91.
   PubMed Web of Science ®Google Scholar
• Afrasiabi GH, Faghihnia TM, Sadeghi F. Surelease as granulating liquid in preparation of sustained release matrices of ethylcellulose and theophylline. Drug Dev Ind Pharm 2014;1–6.
   PubMed Web of Science ®Google Scholar
• Elwerfalli AM, Ghanchi Z, Rashid F, et al. New generation of orally disintegrating tablets for sustained drug release: A propitious outlook. Curr Drug Deliv 2015;12:1–16.
   PubMed Web of Science ®Google Scholar
• British Pharmacopoeia. The Stationery Office on behalf of the Medicines and Healthcare products Regulatory Agency. 2007; Volume 1, Monographs – Medicinal and Pharmaceutical Substances: Domperidone.
   Google Scholar
• U.S. National Library of Medicine: Drug information portal – domperidone. June 2001. Available from: http://druginfo.nlm.nih.gov/drugportal/ [last accessed 21 Nov 2014].
   Google Scholar
• Albright LM. Use of domperidone as a prokinetic and antiemetic. Int J Pharm Compd 2005;9:120–5.
   PubMedGoogle Scholar
• Charles M, Harnett M, Yen M. Domperidone, a new dopamine antagonist. CMAJ 1986;135:457–61.
   PubMed Web of Science ®Google Scholar
• Phutane P, Shidhaye S, Lotlikar V, et al. In vitro evaluation of novel sustained release microspheres of glipizide prepared by the emulsion solvent diffusion-evaporation method. J Young Pharm 2010;2:35–41.
   PubMedGoogle Scholar
• Swain S, Behera UA, Beg SA, et al. Design and characterization of enteric-coated controlled release mucoadhesive microcapsules of Rabeprazole sodium. Drug Dev Ind Pharm 2013;39:548–60.
   PubMed Web of Science ®Google Scholar
• Pepic D, Nikolic M, Grujic S, et al. Release behaviour of carbamazepine-loaded poly(ɛ-caprolactone)/poly(ethylene oxide) microspheres. J Microencapsul 2013;30:151–60.
   PubMed Web of Science ®Google Scholar
• Martinac A, Filipovic-Grcic J, Voinovich D, et al. Development and bioadhesive properties of chitosan-ethylcellulose microspheres for nasal delivery. Int J Pharm 2005;291:69–77.
   PubMed Web of Science ®Google Scholar
• Kimura S, Uchida S, Kanada K, Namiki N. Effect of granule properties on rough mouth feel and palatability of orally disintegrating tablets. Int J Pharm 2015;484:156–62.
   PubMed Web of Science ®Google Scholar
• Jeong S. Fast-melting tablets having taste-masking and sustained release properties. US Patent 2006;20060115529.
   Google Scholar
• Wei Q, Yang F, Luan L. Preparation and in vitro/in vivo evaluation of a ketoprofen orally disintegrating/sustained release tablet. Drug Dev Ind Pharm 2013;39:928–34.
   PubMed Web of Science ®Google Scholar
• Jin Y, Ohkuma H, Wang H, et al. Fast-disintegration oral tablets having sustained release property. YakugakuZasshi 2002;122:989–94.
   PubMed Web of Science ®Google Scholar
• Al-mahallawi AM, Khowessah OM, Shoukri RA. Novel sustained release orally disintegrating tablet containing aceclofenac lipospheres: in-vitro and in-vivo studies. Inventi Impact Pharm Tech 2012;2012.
   Google Scholar
• O'Donnell PB, McGinity JW. Preparation of microspheres by the solvent evaporation technique. Adv Drug Deliv Rev 1997;28:25–42.
   PubMed Web of Science ®Google Scholar
• Yağ G, Çalış S, Arıca-Yegin B. The effect of inorganic salt type and concentration on hydrophilic drug loading into microspheres using the emulsion/solvent diffusion method. Drug Dev Ind Pharm 2014;40:390–7.
   PubMed Web of Science ®Google Scholar
• Dvořáčková K, Doležel P, Mašková E, et al. The effect of acid pH modifiers on the release characteristics of weakly basic drug from hydrophlilic-lipophilic matrices. AAPS PharmSciTech 2013;14:1341–48.
   PubMed Web of Science ®Google Scholar
• Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123–33.
   PubMed Web of Science ®Google Scholar
• Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145–9.
   PubMed Web of Science ®Google Scholar
• European Pharmacopoeia; 6th edition, Council of Europe, Strasburg, 2009;2:1009.
   Google Scholar
• Qi X, Qin J, Ma N, et al. Solid self-microemulsifying dispersible tablets of celastrol: formulation development, charaterization and bioavailability evaluation. Int J Pharm 2014;472:40–7.
   PubMed Web of Science ®Google Scholar
• Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J 2008;22:659–61.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li C, Xu M, et al. Oral bioavailability and gender-related pharmacokinetics of celastrol following administration of pure celastrol and its related tablets in rats. J Ethnopharmacol 2012;144:195–200.
   PubMed Web of Science ®Google Scholar
• Gibaldi M, Perrier D. Pharmacokinetics. (2nd ed.) New York: Marcel Dekker; 1982
   Google Scholar
• Das MK, Rama Rao K. Evaluation of zidovudine encapsulated ethylcellulose microspheres prepared by water-in-oil-in-oil (w/o/o) double emulsion solvent diffusion technique. Acta Pol Pharm 2006;63:141–8.
   PubMedGoogle Scholar
• Shimizu T, Sugaya M, Nakano Y, et al. Formulation study for lansoprazole fast-disintegrating tablet. III. Design of rapidly disintegrating tablets. Chem Pharm Bull 2003;51:1121–7.
   PubMed Web of Science ®Google Scholar
• Das MK, Rao KR. Microencapsulation of zidovudine by double emulsion solvent diffusion technique using ethyl cellulose. Ind Pharm Sci 2007;69:244–50.
   Google Scholar
• Kar M, Choudhury PK. Formulation and evaluation of ethyl cellulose microspheres prepared by the multiple emulsion technique. Pharmazie 2007;62:122–5.
   PubMed Web of Science ®Google Scholar
• Nagarsenker MS, Garad SD, Ramprakash G. Design, optimization and evaluation of domperidone coevaporates. J Control Release 2000;63:31–9.
   PubMed Web of Science ®Google Scholar
• Tiong N, Elkordy AA. Effects of liquisolid formulations on dissolution of naproxen. Eur J Pharm Biopharm 2009;73:373–84.
   PubMed Web of Science ®Google Scholar
• Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413–20.
   PubMed Web of Science ®Google Scholar
• Dhankar V, Garg G, Dhamija K, Awasthi RA. Preparation, characterization and evaluation of ranitidine hydrochloride-loaded mucoadhesive microspheres. Polim Med 2014;44:75–81.
   PubMedGoogle Scholar
• Jameela SR, Misra A, Jayakrishnan A. Cross-linked chitosan microspheres as carriers for prolonged delivery of macromolecular drugs. J Biomater Sci Polym Ed 1994;6:621–32.
   PubMed Web of Science ®Google Scholar
• Michael E. Aulton’s pharmaceutics: the design and manufacture of medicines. 3rd ed. London: Churchill Livingstone; 2007
   Google Scholar
• Thoorens G, Kriera F, Bruno L, et al. Microcrystalline cellulose, a direct compression binder in a quality by design environment – a review. Int J Pharm 2014;473:64–72.
   PubMed Web of Science ®Google Scholar
• Lachman L, Lieberman HA, Kanig JL. The theory and practice of industrial pharmacy, Indian edition, fourth reprint. New Delhi, India: Varghese Publishing House; 1991.
   Google Scholar
• Madgulkar AR, Bhalekar MR, Padalkar RR. Formulation design and optimization of novel taste masked mouth-dissolving tablets of tramadol having adequate mechanical strength. AAPS PharmSciTech 2009;10:574–581.
   PubMed Web of Science ®Google Scholar
• Kumar V, Tiwari D. Dissolution. In: Troy DB, ed. Remington: the science and practice of pharmacy. Philadelphia: Lippincott Williams and Wilkins; 2006:684.
   Google Scholar
• FDA. Guidance for industry: orally disintegrating tablets. Rockville, MD: FDA; 2008. Available from: www.fda.gov/OHRMS/DOCKETS/98fr/FDA-2007-D-0365-gdl.pdf [last accessed July 2015]
   Google Scholar
• McLaughlin R, Banbury S, Crowley K. Orally disintegrating tablets: the effect of recent FDA guidance on ODT technologies and applications. Pharm Technol September 2009:1–18.
   Google Scholar
• Khan S, Kataria P, Nakhat P, Yeole P. Taste masking of ondansetron hydrochloride by polymer carrier system and formulation of rapid-disintegrating tablets. AAPS PharmSciTech 2007;8:46.
   Web of Science ®Google Scholar
• Heykants J, Hendriks R, Meuldermans W, et al. On the pharmacokinetics of domperidone in animals and man. IV. The pharmacokinetics of intravenous domperidone and its bioavailability in man following intramuscular, oral and rectal administration. Eur J Drug Metab Pharmacokinet 1981;6:61–70.
   PubMedGoogle Scholar
• Meuldermans W, Hurkmans R, Swijsen E, et al. On the pharmacokinetics of domperidone in animals and man III. Comparative study on the excretion and metabolism of domperidone in rats, dogs and man. Eur J Drug Metab Pharmacokinet 1981;6:49–60.
   PubMedGoogle Scholar
• Huang YC, Colaizzi JL, Bierman RH, et al. Pharmacokinetics and dose proportionality of domperidone in healthy volunteers. J Clin Pharmacol 1986;26:628–32.
   PubMed Web of Science ®Google Scholar
• Alhumayyd MS, Bukhari IA, Almotrefi AA. Effect of piperine, a major component of black pepper, on the pharmacokinetics of domperidone in rats. J Physiol Pharmacol 2014;65:785–9.
   PubMed Web of Science ®Google Scholar